Startup Launches with $31M to take on 'Chemo Brain'
VC incubator Accelerator Life Science Partners launched its latest biotech startup Monday with a $31 million Series A investment from the likes of Pfizer, Eli Lilly, and AbbVie. The company, Magnolia Neurosciences, aims to develop treatments for a range of neurodegenerative conditions.